{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:55:31Z","timestamp":1790704531427,"version":"4.1.0"},"reference-count":57,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,10,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In vitro studies have documented \u03b22 glycoprotein I (\u03b22GPI) binding to endothelial cells (ECs) and trophoblast using antiphospholipid antibodies. The in vivo binding of \u03b22GPI to these cells and the conditions that favor their interaction have not been investigated. We analyzed the in vivo distribution of cyanine 5.5-labeled \u03b22GPI in mice and evaluated the effect of pregnancy and circulating antibodies on its tissue localization. The signal was detected in the liver by whole body scan and ex vivo analysis. The \u03b22GPI failed to bind to the vascular endothelium and reacted only with the ECs of uterine vessels. In pregnant mice the protein was localized on ECs and trophoblast at the embryo implantation sites. Immunized mice showed a similar \u03b22GPI biodistribution to naive mice but the immunized pregnant animals exhibited a significant increase in fetal loss associated with C3 and C9 deposition at the implantation sites. Treatment of mice with LPS after \u03b22GPI-Cy5.5 injection promoted protein localization on gut and brain ECs associated with IgG, C1q, and C9 deposition in immunized mice. These findings indicate that \u03b22GPI binding to EC requires priming with pro-inflammatory factors which is not needed for uterine and placental localization probably dependent on hormonal changes.<\/jats:p>","DOI":"10.1182\/blood-2011-01-333617","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T20:13:27Z","timestamp":1311711207000},"page":"4231-4238","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":132,"title":["In vivo distribution of \u03b22 glycoprotein I under various pathophysiologic conditions"],"prefix":"10.1182","volume":"118","author":[{"given":"Chiara","family":"Agostinis","sequence":"first","affiliation":[{"name":"Institute for Maternal and Child Health, Istituto di Ricovero e Cura a Carattera Scientifico (IRCCS) Burlo Garofolo, Trieste, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Biffi","sequence":"additional","affiliation":[{"name":"Optical Imaging Laboratory, Cluster in Biomedicine, Trieste, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Garrovo","sequence":"additional","affiliation":[{"name":"Optical Imaging Laboratory, Cluster in Biomedicine, Trieste, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Durigutto","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Trieste, Trieste, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lorenzon","sequence":"additional","affiliation":[{"name":"Optical Imaging Laboratory, Cluster in Biomedicine, Trieste, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpan","family":"Bek","sequence":"additional","affiliation":[{"name":"Optical Imaging Laboratory, Cluster in Biomedicine, Trieste, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bulla","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Trieste, Trieste, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Grossi","sequence":"additional","affiliation":[{"name":"Laboratory of Immuno-Rheumatology, IRCCS Istituto Auxologico Italiano, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria O.","family":"Borghi","sequence":"additional","affiliation":[{"name":"Laboratory of Immuno-Rheumatology, IRCCS Istituto Auxologico Italiano, Milan, Italy;"},{"name":"Department of Internal Medicine, University of Milan, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PierLuigi","family":"Meroni","sequence":"additional","affiliation":[{"name":"Laboratory of Immuno-Rheumatology, IRCCS Istituto Auxologico Italiano, Milan, Italy;"},{"name":"Department of Internal Medicine, University of Milan, Milan, Italy; and"},{"name":"Division of Rheumatology, Istituto G. Pini, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tedesco","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Trieste, Trieste, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111813595626000_B1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies.","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"2019111813595626000_B2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0028-1082267","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.","volume":"34","author":"Pierangeli","year":"2008","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"2019111813595626000_B3","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","article-title":"Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor.","volume":"106","author":"Fischetti","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2019111813595626000_B4","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/ard.2006.065037","article-title":"Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies.","volume":"66","author":"Pierangeli","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"43","key":"2019111813595626000_B5","doi-asserted-by":"crossref","first-page":"13833","DOI":"10.1021\/bi960657q","article-title":"Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes.","volume":"35","author":"Willems","year":"1996","journal-title":"Biochemistry"},{"issue":"2","key":"2019111813595626000_B6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.clim.2004.02.014","article-title":"Beta-2 glycoprotein I and its role in antiphospholipid syndrome-lessons from knockout mice.","volume":"112","author":"Miyakis","year":"2004","journal-title":"Clin Immunol"},{"issue":"2","key":"2019111813595626000_B7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0021-9150(99)00496-7","article-title":"Beta(2)-glycoprotein I deficiency: prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis.","volume":"152","author":"Yasuda","year":"2000","journal-title":"Atherosclerosis"},{"issue":"4","key":"2019111813595626000_B8","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V96.4.1594","article-title":"Coagulation and fibrinolytic activities in 2 siblings with beta(2)-glycoprotein I deficiency.","volume":"96","author":"Takeuchi","year":"2000","journal-title":"Blood"},{"issue":"6","key":"2019111813595626000_B9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/molehr\/gah058","article-title":"Effect of beta2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice.","volume":"10","author":"Robertson","year":"2004","journal-title":"Mol Hum Reprod"},{"issue":"11","key":"2019111813595626000_B10","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).","volume":"87","author":"McNeil","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8708","key":"2019111813595626000_B11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0140-6736(90)91697-9","article-title":"Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease.","volume":"336","author":"Matsuura","year":"1990","journal-title":"Lancet"},{"issue":"9","key":"2019111813595626000_B12","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/j.1538-7836.2005.01485.x","article-title":"Lupus anticoagulants and the risk of a first episode of deep venous thrombosis.","volume":"3","author":"de Groot","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111813595626000_B13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2019111813595626000_B14","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2019111813595626000_B15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.RES.88.2.245","article-title":"Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin.","volume":"88","author":"Pierangeli","year":"2001","journal-title":"Circ Res"},{"issue":"11","key":"2019111813595626000_B16","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"issue":"1 Pt 1","key":"2019111813595626000_B17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0002-9378(11)90700-5","article-title":"Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB\/c mice: a model for autoimmune fetal loss.","volume":"163","author":"Branch","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2019111813595626000_B18","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1172\/JCI115749","article-title":"Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).","volume":"89","author":"Bakimer","year":"1992","journal-title":"J Clin Invest"},{"key":"2019111813595626000_B19","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1177\/096120339800700211","article-title":"Beta2-glycoprotein I as a \u2018cofactor\u2019 for anti-phospholipid reactivity with endothelial cells.","volume":"7","author":"Meroni","year":"1998","journal-title":"Lupus"},{"issue":"10","key":"2019111813595626000_B20","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/0961203308096344","article-title":"Platelets and the antiphospholipid syndrome.","volume":"17","author":"Urbanus","year":"2008","journal-title":"Lupus"},{"issue":"4","key":"2019111813595626000_B21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3892\/ijmm_00000265","article-title":"Annexin A2 mediates anti-beta 2 GPI\/beta 2 GPI-induced tissue factor expression on monocytes.","volume":"24","author":"Zhou","year":"2009","journal-title":"Int J Mol Med"},{"key":"2019111813595626000_B22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1196\/annals.1422.054","article-title":"Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies: a review of the literature.","volume":"1108","author":"Di Simone","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"2019111813595626000_B23","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2002-08-2349","article-title":"Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies.","volume":"101","author":"Raschi","year":"2003","journal-title":"Blood"},{"issue":"8","key":"2019111813595626000_B24","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/art.22802","article-title":"Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts.","volume":"56","author":"Sorice","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2019111813595626000_B25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1177\/0961203308095329","article-title":"Annexin A2: biology and relevance to the antiphospholipid syndrome.","volume":"17","author":"Cockrell","year":"2008","journal-title":"Lupus"},{"issue":"1","key":"2019111813595626000_B26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.autrev.2009.02.025","article-title":"Beta2-glycoprotein I and annexin A5 phospholipid interactions: artificial and cell membranes.","volume":"9","author":"Frank","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"4","key":"2019111813595626000_B27","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2010-07-299099","article-title":"Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome.","volume":"117","author":"Romay-Penabad","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111813595626000_B28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1172\/JCI39828","article-title":"Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via beta2GPI and apoER2.","volume":"121","author":"Ramesh","year":"2011","journal-title":"J Clin Invest"},{"issue":"44","key":"2019111813595626000_B29","doi-asserted-by":"crossref","first-page":"36729","DOI":"10.1074\/jbc.M504172200","article-title":"The binding site in {beta}2-glycoprotein I for ApoER2\u2032 on platelets is located in domain V.","volume":"280","author":"van Lummel","year":"2005","journal-title":"J Biol Chem"},{"issue":"8","key":"2019111813595626000_B30","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/art.21968","article-title":"Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V.","volume":"54","author":"Shi","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2019111813595626000_B31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/jaut.2000.0412","article-title":"Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome.","volume":"15","author":"Meroni","year":"2000","journal-title":"J Autoimmun"},{"issue":"4","key":"2019111813595626000_B32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/0961203309360810","article-title":"Role of tissue factor in thrombosis in antiphospholipid antibody syndrome.","volume":"19","author":"Boles","year":"2010","journal-title":"Lupus"},{"issue":"2","key":"2019111813595626000_B33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/humupd\/dml051","article-title":"Pathogenic role of anti-beta2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin.","volume":"13","author":"Di Simone","year":"2007","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2019111813595626000_B34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0961203309361351","article-title":"Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view.","volume":"19","author":"Meroni","year":"2010","journal-title":"Lupus"},{"issue":"19","key":"2019111813595626000_B35","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1093\/emboj\/18.19.5166","article-title":"Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure.","volume":"18","author":"Bouma","year":"1999","journal-title":"EMBO J"},{"issue":"2","key":"2019111813595626000_B36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-5793(92)81442-O","article-title":"Activity, disulphide mapping and structural modelling of the fifth domain of human beta 2-glycoprotein I.","volume":"313","author":"Steinkasserer","year":"1992","journal-title":"FEBS Lett"},{"issue":"8","key":"2019111813595626000_B37","first-page":"267","article-title":"Pathophysiology of antiphospholipid antibodies.","volume":"62","author":"de Groot","year":"2004","journal-title":"Neth J Med"},{"issue":"2","key":"2019111813595626000_B38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/jaut.2000.0427","article-title":"Epitope studies with anti-beta 2-glycoprotein I antibodies from autoantibody and immunized sources.","volume":"15","author":"Reddel","year":"2000","journal-title":"J Autoimmun"},{"issue":"1","key":"2019111813595626000_B39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/art.22306","article-title":"Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43.","volume":"56","author":"Ioannou","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2019111813595626000_B40","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1538-7836.2009.03316.x","article-title":"In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of beta2-glycoprotein I: proof of concept.","volume":"7","author":"Ioannou","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"3\u20134","key":"2019111813595626000_B41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0897.1992.tb00773.x","article-title":"Immune recognition at the maternal-fetal interface: overview.","volume":"28","author":"McIntyre","year":"1992","journal-title":"Am J Reprod Immunol"},{"issue":"9","key":"2019111813595626000_B42","first-page":"1684","article-title":"Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome.","volume":"21","author":"La Rosa","year":"1994","journal-title":"J Rheumatol"},{"issue":"4","key":"2019111813595626000_B43","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1160\/TH08-02-0082","article-title":"Anti-beta(2)-glycoprotein I ELISA assay: the influence of different antigen preparations.","volume":"101","author":"Cavazzana","year":"2009","journal-title":"Thromb Haemost"},{"issue":"7","key":"2019111813595626000_B44","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1364\/OPEX.13.002263","article-title":"Time Domain Fluorescent Diffuse Optical Tomography: analytical expressions.","volume":"13","author":"Lam","year":"2005","journal-title":"Opt Express"},{"issue":"5","key":"2019111813595626000_B45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2310\/7290.2007.00030","article-title":"In vivo time domain optical imaging of renal ischemia-reperfusion injury: discrimination based on fluorescence lifetime.","volume":"6","author":"Abulrob","year":"2007","journal-title":"Mol Imaging"},{"issue":"5","key":"2019111813595626000_B46","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.cbpa.2003.08.007","article-title":"In vivo near-infrared fluorescence imaging.","volume":"7","author":"Frangioni","year":"2003","journal-title":"Curr Opin Chem Biol"},{"issue":"5","key":"2019111813595626000_B47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.it.2005.03.006","article-title":"Humoral autoimmunity against endothelium: theory or reality?","volume":"26","author":"Meroni","year":"2005","journal-title":"Trends Immunol"},{"issue":"12","key":"2019111813595626000_B48","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1191\/0961203303lu503oa","article-title":"Endothelium and the brain in CNS lupus.","volume":"12","author":"Meroni","year":"2003","journal-title":"Lupus"},{"issue":"9","key":"2019111813595626000_B49","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.molimm.2007.12.025","article-title":"Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium.","volume":"45","author":"Bulla","year":"2008","journal-title":"Mol Immunol"},{"issue":"8","key":"2019111813595626000_B50","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/j.1538-7836.2008.03021.x","article-title":"Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2\u2032.","volume":"6","author":"Urbanus","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111813595626000_B51","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1074\/jbc.M008224200","article-title":"Dimers of beta 2-glycoprotein I mimic the in vitro effects of beta 2-glycoprotein I-anti-beta 2-glycoprotein I antibody complexes.","volume":"276","author":"Lutters","year":"2001","journal-title":"J Biol Chem"},{"issue":"9090","key":"2019111813595626000_B52","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(05)63936-0","article-title":"From antiphospholipid syndrome to antibody-mediated thrombosis.","volume":"350","author":"Roubey","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"2019111813595626000_B53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12016-009-8183-5","article-title":"Complement activation and pregnancy failure.","volume":"39","author":"Tincani","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"2019111813595626000_B54","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1073\/pnas.88.8.3069","article-title":"Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.","volume":"88","author":"Blank","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2019111813595626000_B55","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.","volume":"112","author":"Girardi","year":"2003","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111813595626000_B56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med"},{"issue":"1","key":"2019111813595626000_B57","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/ard.2005.045443","article-title":"Infectious origin of the antiphospholipid syndrome.","volume":"65","author":"Shoenfeld","year":"2006","journal-title":"Ann Rheum Dis"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/15\/4231\/1342446\/zh804111004231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/15\/4231\/1342446\/zh804111004231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T14:00:36Z","timestamp":1574085636000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/15\/4231\/29039\/In-vivo-distribution-of-%CE%B22-glycoprotein-I-under"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,13]]},"references-count":57,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2011,10,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-01-333617","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,13]]}}}